Inside EU Health Inside EU Health: Swedes hold key to tobacco taxation; economic cost of menopause; Finnish first in AI and health Sweden could be the last obstacle to a tobacco and nicotine tax agreement; menopause costs the EU economy €17.3 billion a year; Finland backs a world-first nationwide AI model to boost decision-making in healthcare
Inside EU Health Inside EU Health: Pharmacists ‘on the front lines’ of Europe’s medicine shortages; untreated menopause's cost on productivity; long term impact of Long COVID Pharmacists ‘on the front lines’ of Europe’s medicine shortages; untreated menopause has a €17 billion cost on productivity; Study highlights reduced ability to work among people with Long COVID
EMA EMA recommends approval of six medicines, expands indications for nine EMA recommended six medicines for approval at its meeting and extended the therapeutic indications of nine medicines.
Hormone replacement therapy EMA says ‘no new evidence’ to support changes to HRT warnings The European Medicines Agency (EMA) says it has seen no new evidence that points to a need to amend the current labelling of HRT medicines
